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DESIGN OF A BLOOD-FREEZING SYSTEM
FOR LEUKEMIA RESEARCH
Thomas E. Williams and Thomas A. Cygnarowicz
Goddard Space Flight Center
Greenbelt, Maryland
INTRODUCTION
Leukemia is a disease characterized by a proliferation of the tissue that forms white blood
cells. Although the number of white cells in the blood may either increase, decrease, or re-
main constant during this disease, the bone marrow in which the cells are formed proliferates.
Treatment of leukemia involves the use of drugs or radiation to kill the cancerous white cells
in the blood and bone marrow. This process can cause loss of all bone marrow so that nor-
mal white-cell production is not possible. When this loss occurs, white cells must be supplied
to the patient.
Several factors make white cells much more difficult to use than whole blood. First, because
of the nature of the disease and to prevent rejection, the patient-donor white-cell types, of
which there are over eighty, must match. Second, because the normal storage life of white
cells is limited to several hours, they must be used immediately after they are donated.
Finally, because it takes about 4 hours to obtain a unit of white cells from a donor, the time
factor is critical.
For some years, the Experimental Hematology Branch at the National Cancer Institute (NCI)
has been working on techniques for freezing and storing white blood cells. The goal of NCI
is to establish a bank or storage facility for white cells. NCI has found that white cells are
considerably more difficult to freeze and store than red blood cells, and believes the most
important parameter during the freezing process is the rate of temperature change. Experi-
ments have shown that improved yields of white blood cells result when rudimentary con-
trols are placed on the rate of temperature change. Experimental evidence indicates that,
if the cells are cooled too quickly, they are destroyed by rupture of the cell membrane. If
they are cooled too slowly, they are destroyed by dehydration.
The biological freezing equipment previously used by NCI (discussed in Appendix A) did
not permit direct control over the blood temperature, and, consequently, large deviations
from the desired rate oftemperature change occurred during the freezing process. In
addition, because of sample-to-sample variations, the freezing rates were not consistent or
repeatable. Testing had advanced to the point where they needed a system that could freeze
different lots of blood in a repeatable manner, and NCI sought technical assistance in develop-
ing such a system. In conjunction with NCI, the Technology Utilization (TU) Office at
National Aeronautics and Space Administration (NASA) Headquarters asked the Goddard
Space Flight Center (GSFC) to develop the system to meet requirements specified by the
researchers.
The basic requirement was to develop a unit that could freeze up to 200 milliliters of white
cells from room temperature to 223 K (-50°C) at a constant rate of temperature change. The
rate was to be selectable in the range of 1 to 4 K per minute. Special considerations that
would directly affect the design were:
• The cooling and freezing characteristics of the white cells and the chemical medium
in which they were stored was unknown.
• The concentration of cells and chemical medium could change from sample to
sample.
• The white cells and chemicals would have to be maintained in a sterile environment
throughout the entire process (before, during, and after freezing).
• Control would have to be maintained while the heat of fusion was being released.
The primary problem in maintaining constant rate of temperature change is that
the specific heat of the fluid being frozen changes and the heat of fusion must be
released at the freezing point. A further complication is the fact that the heat of
fusion and specific heat vary from sample to sample.
• The freezing temperature of the blood sample is unknown and cannot be prede-
termined (i.e., it varies from sample to sample).
During the early phases of the effort, GSFC personnel spent some time with the researchers
at NCI in order to fully understand their operation and to determine what they expected
from the new system. As a result, it was determined that much of the early experimental
and analytical work could not be used in the design of the final system. Because of their
technical value and their usefulness in interpreting the experimental test results of the
freezing system, the results of this work have been included in Appendix A.
The main portion of this document deals with the freezing system that was designed, assem-
bled, and tested by GSFC and delivered to NCI.
The Problem
The basic requirement for this program was to develop a system capable of controlling the
freezing rate of white blood cells in a dimethylsulfoxide (DMSO) solution. The fluid would
have to be kept in a sterile bag before, during, and after freezing. Cooling rates of 1 to 4 K
per minute were desired for samples ranging up to 200 milliliters.
The problem that NCI experienced in attempting to obtain a constant rate of temperature
change while freezing white blood cells is primarily the result of two changes that occur in
the fluid during the cooling/freezing processes. First, the specific heat of the blood/chemical
mixture changes with temperature. Second, in the temperature range at which the liquid is
actually freezing, the heat of fusion must be extracted. If a constant rate of temperature
change is to be maintained, the heat extraction rate must be adjusted accordingly. Figure 1
is a typical freezing curve taken from an actual test using a blood/chemical mixture. The
dotted line indicates the temperature of the inside of the biological freezer, and the solid line
shows the temperature of the blood container.
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Figure 1. Blood cell/DMSO freezing curve.
For this test, the blood was placed in the freezer at 293 K, and the freezer was cooled at a
constant rate of 2 K per minute. Figure 1 shows that the cooling rate of the blood was not
constant. The first deviation occurred at 257 K when the blood container temperature
quickly rose from the supercooled temperature of 257 K up to the normal freezing point
(for this sample) of 260 K where the actual freezing process took place. Because the heat-
pumping capacity of the freezer is essentially constant under these conditions, the heat of
fusion of the sample cannot be pumped out fast enough, and the blood temperature drops
much more slowly than is desired. When the blood container reaches about 238 K and the
sample becomes totally frozen, the temperature begins to drop rapidly and eventually re-
turns to the desired -2 K per minute rate of change. The objective is to provide an adjustable
heat-extraction capability so that the blood will be cooled at a constant temperature rate.
SYSTEM CONCEPT
Experimental attempts to adjust the heat-pumping capacity by controlling the freezer tem-
perature proved inadequate. Because of its size, the freezer could not react quickly when a
change in thermal environment was required. Changes in the blood sample occurred, too
quickly for the freezer to follow. Various other commercial freezing systems and proposed
concepts (Appendix A) were rejected for either this or other reasons, such as incompatibility
with the sterility requirement, NCI handling requirements, or NCI facilities.
A system was developed that could rapidly change its heat extraction capacity, would have
minimum impact on NCI facilities and procedures, and would also satisfy all other require-
ments. This system, shown diagrammatically in figure 2 and photographically in figure 3,
consists of three basic subsystems: gaseous nitrogen freezer, blood-container assembly, and
electronic control unit.
Figure 2. Freezing system block diagram.
The freezer used in this system is a standard biological unit that has a centrifugal blower to
circulate cold gaseous nitrogen around the specimens to be frozen. The cold gas comes from
an external liquid-nitrogen source and is used to automatically control and adjust the freezer
temperature.
Figures. Complete freezing system.
The blood-container assembly consists of a polyethylene bag (for containing the white blood
cells) that is sandwiched between two hardened aluminum plates. The outer surfaces of both
plates are covered with printed-circuit heaters. The freezer temperature is dropped low enough
to equal or exceed the maximum cooling rate needed at any time during the freezing process.
Heater power is applied to the plates to make up the difference between the heat leaving the
blood sample and that required to maintain the specified temperature difference between
the freezer and the plates. Reducing the heater power increases the heat-pumping rate
from the blood to the cold gas, and raising the heater power decreases the heat-pumping
rate. A thermocouple mounted on the inner surface of one plate monitors the blood-bag
temperature. Mounting a thermocouple directly in the blood is impractical because a uni-
form position cannot be maintained and it would compromise the sterile requirement.
The electronic control unit compares the thermocouple (blood temperature) signal with a
programmer that contains the desired temperature/time curve. It then controls the power
to the heaters to keep the blood temperature at the programmed setting.
In operation, the sandwich assembly containing the blood sample is placed inside the freezer
containing the cold gas. The heaters turn on immediately to prevent removal of heat from
the blood. From this point, the heater power is automatically controlled by the electronics
so that the temperature at the thermocouple tracks the desired profile that is stored in the
temperature programmer. For example, if the temperature of the blood begins to increase
because of the supercooling effect, the electronics sense the condition and automatically
reduce the heater power. This increases the heat flow through the plates to the cooling gas
and keeps the blood temperature falling at the desired rate. If the blood begins to cool too
quickly (e.g., when the 293-K liquid is placed in the cold freezer), the electronics also sense
this condition and increase the heater power to maintain the desired rate.
Figure 4 is a graph of the results obtained from freezing a sample of white blood cells. In
this case, the blood temperature cooled at the constant rate that was preset on the program-
mer, independent of the freezer-gas temperature. The freezer-gas temperature can be dropped
either at a controlled rate or immediately to a lower limit. The only restriction on the freezer
is that it be at least 288 K, but not more than 333 K, colder than the desired blood temperature
at any given time. The results in figure 4 differ from those in figure 1, which were obtained
when freezing the same sample without the electronic controls.
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Figure 4. Freezing results of new system.
THERMAL SIMULATION OF FREEZING PROCESS
Early in the program, a thermal analysis was undertaken to:
• Evaluate performance of different cooling systems to determine optimum type
of system
• Make hardware design tradeoffs for each system
• Investigate system operational procedure tradeoffs
• Obtain a complete temperature profile of the system and of the fluid for evalu-
ating test data because existing data indicate that the rate of temperature change
during freezing of white cells is important in improving yield
In setting up the analysis, every attempt was made to keep the criteria flexible enough to
evaluate different types of systems and to permit hardware changes, heater location changes,
etc.
The general one-dimensional energy equation with heat generation results in a partial dif-
ferential equation. This equation would be difficult, if not impossible, to solve for the com-
posite structure with a liquid changing phase to a solid. Consequently, a finite-element
forward-difference numerical solution was pursued. Consider the nodal points shown in
figure 5. In general, a heat summation at any nodal point n (figure 6) results in the
following (when Tn+ l > Tn):
FT T 1
(n + 1 ) - (n) [> + 1) n "
'(n) (n) J (1)
BAG
PLATE.
COOLING
MEDIA
.FLUID
n-1 n n+1
Figure 5. Finite difference heat transfer model.
Each part of the system is broken into one or more nodal volumes, and a finite-difference
energy equation similar to equation 1 is written for each node. The q'" term drops out
for all nodes except those having a heater.
Heat transfer through the fluid depends on the state of the fluid. The analysis must account
for three possible states:
• The fluid is in the liquid state
• The fluid is in the two-phase regime
• The fluid has frozen
When the fluid is in the liquid state, the properties of the liquid are used, and the finite-
difference heat-transfer analysis proceeds as for any homogeneous region. The same is true
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Figure 6. Nodal heat summation.
when the fluid has solidified, except that the properties of the solid are used. The method
of handling the fluid/solid mixture during the freezing process is considerably more diffi-
cult.
When a liquid reaches its freezing temperature, no temperature change will occur (excluding
subcooling effects) until it has frozen completely. The procedure used divides the liquid
into thin layers, with a nodal point in the center of each layer. It is assumed that the liquid
in the layer at the n*1 node will not begin to freeze until the liquid in the layer at the (n-1)
node has completely frozen. This assumption is reasonable for a substance that freezes at a
constant temperature because a temperature differential is required to transfer heat from
the ntfl to the n-1 node, and Tn cannot reach the freezing temperature until Tn t drops below
the freezing temperature. It is further assumed that the contents of each layer are homo-
geneous. (While the heat of fusion is being released, the accuracy of this assumption is
dependent on the size of the layers (i.e., the number of divisions in the bag).)
The question arises as to what properties to use when the freezing is initiated in a particular
layer. This analysis assumes that the temperature of the layer is constant and uniform until
complete freezing has occurred and that the thermodynamic properties are proportional
to the amount of heat that has been released after reaching the freezing point. For example,
consider a property, n, where n is the property of the solid, and nf is the property of the
liquid. Let Hrf be the heat of fusion, and let Q be the amount of heat released during the
time period since the freezing point was reached. The property, n, at this time is given by
/ Q \ Q
n = I 1 I n, +
V Hsf/ ' Hsf
(2)
s
Equation 2 is used only in the two-phase region (i.e., during freezing).
The resulting analysis was programmed for a digital computer. The program listing appears
in Appendix B.
One of the inherent problems with a forward-difference solution is that the time and dis-
tance steps that are chosen must be small enough to keep the solution stable. In this case,
a trial and error solution was used that resulted in the selection of 20 nodes in the fluid with
a time step of about 0.01 seconds.
The computer analyses, hand calculations, and laboratory tests were used to evaluate various
freezing-system designs. The details of some of these analyses and tests are contained in
Appendix A. This discussion is limited to the system selected.
The initial configuration for the system analyzed used the same materials then in use at
NCI (i.e., a polyvinylchloride (PVC) bag sandwiched between two brass plates). Early
analyses immediately indicated that the freezing control and the response of the fluid to
cooling-system changes could be improved by reducing the thermal resistance between the
cooling fluid and the fluid being cooled. This was accomplished by switching to thinner
materials with higher thermal conductivity and lower thermal mass. The brass plates were
replaced with aluminum, and the PVC bags were replaced with thinner polyethylene bags.
Some of the earlier concepts proposed for the freezing system neglected any consideration
of the latent heat of fusion, which must be removed to solidify the liquid. The solidifying
solution and the components between the solution and the cooling media result in a finite
time required for removing the latent heat of fusion. Analyses conducted with water prop-
erties resulted in a cooling/freezing temperature profile as shown in figure 7. The sub-
scripts 1,3,4, and 6 refer to the cooling gas, the outside of the bag, the first layer of water
inside the bag, and the water in the middle of the bag, respectively. It is important to note
that even if the bag temperature/time profile is controlled, the temperature/time profile
of the fluid inside the bag will be different. In the case analyzed, the actual freezing of the
solution was totally dependent on the thermal properties of the white blood cell solution
and the system used for the freezing. No electronic circuitry can make the freezing unit
perform beyond its thermodynamic limitations.
Figure 8 shows the results of a test that was conducted to duplicate the conditions used in
water analyses. Good agreement exists between the analysis and test results shown in
figures 7 and 8, respectively.
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Figure 7. Computer generated freezing curve for water.
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Figure 8. Test generated freezing curve for water.
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Although the use of water properties enabled the system tradeoffs to be made with the com-
puter program, more difficult problems were encountered in considering a DMSO solution.
Freezing tests conducted with a thermocouple inside a bag of DMSO solution (50-percent
DMSO and 50-percent water) showed that the solution experiences a definite subcooling
effect of about 3 K. (Some tests with water showed a slight subcooling effect, but it was
not repeatable with the accuracy of the test setup.) Figure 9 shows the results of one test.
The results show that the solution does not remain at a constant temperature during the
freezing process. The specific heat appears to be a function of the amount of fluid that
has solidified. Although it was beyond the scope of this program to determine actual thermal
properties of the DMSO solution, some effort was made to duplicate the experimental
data on the computer program by comparing the experimental data for DMSO to that of
water and using a proportionality constant. The properties and resulting temperature pro-
file are shown in figure 9.
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Figure 9. DMSO freezing curve.
Because the optimum freezing process for the white blood cells is unknown, one of the
uses of the computer program is to determine a bag-temperature profile that will result in
a specified cooling curve at a point within the fluid. It could also be used as a research tool
to investigate the effects of different cooling-fluid temperatures on the freezing rate
within the solution in the bag. Figure 10 shows the results of an analysis to determine the
cooling-gas temperature required for maintaining the bag cooling rate at 2 K per minute.
Figure 10 also shows the temperature within the fluid. These data indicate how the fluid
temperature compares to the bag temperature.
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SYSTEM DESIGN
Blood-container Assembly
As previously stated, the blood-container assembly consists of a polyethylene bag sandwiched
between aluminum plates that have heaters mounted to their exterior surface. This con-
figuration was selected for the following reasons:
• Analyses indicated a need for a thin section to minimize thermal gradients within
the blood.
• It was compatible with the standard blood-retainer-bag configuration.
• It provides more easily analyzed and adaptable one-dimensional heat flow.
• It simplifies heater installation.
• It is compatible with the readily available gaseous-nitrogen freezers.
Figure 11 shows the unit used for most of the developmental work. This unit measures
13 by 18 cm and is designed to hold up to 100 milliliters of white blood cells. A larger
bag and assembly, now in use at NCI, are described later in this section.
The bag is made of polyethylene with a wall thickness of 0.05 millimeters. Polyethylene is
a comparatively good thermal conductor for this type of application. This fact, combined
with the thin wall, provides for good thermal conductance. A self-sealing port permits the
cells to be injected and withdrawn under sterile conditions. These bags are commercially
12
Figure 11. Blood container and electronic control unit.
available. The sandwich plates are made of 0.75-mm thick hardened aluminum for good
mechanical stiffness and high thermal conductivity. The surface is chemically etched to
provide a good bond with the heaters.
The heaters consist of copper-alloy foil sandwiched between two layers of Kapton film.
Their total thickness is less than 0.2 millimeters. This design element helps to minimize the
thermal-resistance path and to provide fast thermal response because of the small thermal
capacity of the heaters. The maximum power requirement for the heaters depends on both
the gas-flow rate of the freezer being used and on the maximum desired cooling rate of the
blood (4 K/minute). It was experimentally determined that 280 watts would be the maxi-
mum power required for this configuration, and the final heaters were selected accordingly.
A hole was drilled through the heater/plate assembly, and a thermocouple was passed through
and was permanently mounted on the inside surface of the plate so that it touches the bag.
During the freezing process, the entire assembly is held together at the edges of the aluminum
plates by a fiberglass channel. Because the container is mounted vertically (in line with
freezer-gas flow), the moderate hydrostatic pressure of the liquid in the bag tends to push
the plates apart. The plates are sufficiently stiff to prevent more than negligible bending,
and a uniform thickness of the blood sample results.
When the development work on this assembly was complete, NCI expressed a desire to
freeze up to 200 milliliters of white blood cells at one time. With the 13- by 18-cm bag, this
would have meant increasing the sectional thickness of the blood from about 5 millimeters
to 10 millimeters. Because of the thermal resistance of the blood/chemical mixture to
heat flow, this was totally undesirable. Consequently, a new blood-container assembly was
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designed. A new polyethylene bag measuring 28 by 28 cm was commercially available, and
the new assembly was designed to accommodate that bag. To permit sufficient clearance,
the plate surface was increased to 30 by 30 cm.
Because of the increased size of the new assembly, the effects of hydrostatic pressures within
the bag necessitated that the sandwich assembly be redesigned. Because it was not thermally
desirable to increase the thickness of the aluminum plate, the edge-holding technique used in
the 13- by 18-cm assembly was no longer adequate. After considering various alternatives,
a fiberglass reinforced structure was selected. The plate is supported around its perimeter
and at every 4 cm over the entire surface. It was designed to be stiff enough to prevent the
thickness of the blood sample from deviating more than 0.02 millimeters from nominal.
Figure 12 shows the entire assembly. Specially made aluminum clamps hold the assembly
together. Four sets of clamps permit this unit to freeze volumes of 60 to 220 milliliters.
With the larger bag, a bigger freezer was used, and the maximum heater power had to be
increased to 670 watts. The control system and electronics remained the same as those
designed for the 13- by 18-cm bag.
Figure 12. 30- by 30-cm blood container.
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Electronics
The purpose of the electronic control unit is to automatically control the power into the
heaters and thereby to control the blood temperature. Several types of circuits were con-
sidered, and two were tried before the final design was made. Two circuits were rejected:
• A de-powered pulse-width-modulated circuit had two serious drawbacks. First,
because of the large amount of heater power required, a large dc supply was
needed, adding considerable weight and cost to the system. Second, switching
of the large currents created system noise problems.
• An ac-powered variable phase-angle circuit eliminated the power-supply require-
ment, but still created too much noise.
These problems were eliminated by using a time-proportioning temperature-control circuit
with the following primary characteristics:
• Provides proportional control—output power is proportional to temperature error
• Proportional bandwidth-0.5 K
• Recycling period—500 milliseconds
• Power output—up to 1500 watts continuous
• Remotely programmable
• Relatively few components
• No noise problems attributable to zero-crossing firing
Figures 3 and 11 show the electronics unit, and figure 13 shows the entire schematic. The
circuitry can be easily understood by referring to the diagram shown in figure 13. The thermo-
couple next to the blood bag (TCI) is connected to a semiconductor reference junction that is
connected to amplifier A4 and is amplified by 1000. This high-level signal is then provided
at TBS for display on a recorder. The signal is also fed into amplifier A2 where it is com-
pared with the signal from the potentiometer in the bag-temperature programmer. The
greater the difference in these signals, the greater the output voltage from A2. This error
voltage is fed to one input of a //a 742 zero-crossing ac trigger. In conjunction with the two-
transistor ramp generator, the pa 742 provides trigger pulses to the RCA 40802 Triac at the
zero crossing of the load current when the input error voltage exceeds the level of the ramp
generator. The number of output cycles during each 500-millisecond period is proportional
to the error voltage. The resultant resolution is 1/60 K with a full power bandwidth of
1/2 K. The circuit is capable of going from zero to full power in 0.5 second.
Thermocouple TC2 and its associated amplifier, A3, is used to measure the freezer-gas
temperature. This circuit was added for convenience and has no direct control function.
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Freezer
The freezer used in this system is a commercially available biological cryogenic freezer. These
freezers are capable of high cooling rates; they can be quickly recycled back to ambient
temperature, and they are easy to operate. The cooling medium is circulated cold-nitrogen
gas that is obtained from an external liquid-nitrogen supply. Temperature control is achieved
by automatically controlling the flow of nitrogen into the freezing chamber. Temperatures
as low as 173 K are readily achieved and maintained.
The primary requirements of the freezer are that it be physically capable of accepting the
blood-container assembly and that it be capable of extracting heat from the blood at the
maximum rate desired during the freezing process. The nitrogen freezers satisfy these require-
ments and are also simple to operate and trouble-free.
TEST RESULTS
GSFC conducted extensive tests, using the entire freezing system as shown in figure 3. These
tests included various blood quantities up to 100 milliliters, various freezing rates from 1 K per
minute to 4 K per minute, and a wide range of combinations of blood-cell/chemical concen-
trations. The system performed as required during all of these tests. That is, the freezing rate
was constant (figure 4) while freezing from 293 to 223 K and was independent of blood
volume or concentration.
Because the available freezer was not large enough, GSFC could not test the 30- by 30-cm
blood-container assembly before delivering it to NCI. NCI conducted tests at its research
facility using various volumes (60 to 220 milliliters) and various blood samples, but at only
1 K per minute. All systems worked very well. No testing was done at the higher freezing
rates because NCI research was being done at 1 K per minute and NCI was anxious to get the
entire system in service.
CONCLUSIONS
The system described in this document was turned over to the Experimental Hematology
Branch (EHB) at the National Cancer Institute for its use in leukemia research and is now
fully operational. EHB's current work with the system involves freezing bone marrow and
white blood cells from dogs and using it for later transfusions. Since January 1975, many
dogs who have had their bone marrow and white blood cells destroyed by radiation have
survived because of subsequent transfusions of the previously frozen blood. These results
have been encouraging, and more extensive and critical tests are now underway. This sys-
tem has improved the researchers' procedure and technique and has provided a system
adaptable to their research requirements.
The system could conceivably be applied to freezing other biological samples that require a
strict control on the freezing rate.
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APPENDIX A
EVALUATION OF FREEZING SYSTEM CONCEPTS
APPENDIX A
EVAULATION OF FREEZING SYSTEM CONCEPTS
Before the freezing system design described in the main text of this document was selected,
a number of other concepts were considered. In addition to the performance requirements,
other factors considered were practicality of fabrication, ease of later system modification,
convenience of use, and cost.
Early in the program, a number of tests were conducted with the freezer system that NCI
was then using to gain insight into the problems involved and to provide possible ideas for
improving the freezing system design. Some shortcomings of that system are described in
the following paragraphs.
With all systems considered, before the freezing process began, the cells were mixed with a
cryoprotective agent in an ampule or sample bag. Typically, in the procedures previously
employed, the container was then placed in a standard biological freezer. The freezer used
liquid nitrogen that vaporized to provide cooling gas to which heat was transferred from the
sample being frozen. The system was programmed to drop the cooling-gas temperature at
a desired rate; i.e., control was maintained over the cooling gas, not the freezing sample
(although the temperature of the outside surface of the sample container was monitored
and recorded). After the sample was completely frozen, it was quickly transferred to a
storage freezer where it was kept until needed.
One significant disadvantage of this technique is that temperature control of the cooling
gas was maintained rather than the sample being frozen. Variations in thermal properties
and quantity being frozen from one sample to another result in widely varying sample-freezing
rates. This is unsatisfactory because existing test data indicate that cell viability is strongly
dependent on freezing rate.
Modifications of the foregoing technique could provide some improvement. For example,
the temperature of the sample being frozen could be used to control the flow of liquid
nitrogen to the freezing chamber. However, freezer-gas temperature response is slow, and
a uniform repeatable freezing curve for the sample cannot be maintained.
Another possible modification involves increasing the flow of liquid nitrogen to the freezer
chamber when the sample being frozen reaches the freezing point. In reality, the liquid
experiences a subcooling effect near the freezing point. The temperature drops below the
freezing temperature until freezing begins and rises a few degrees when freezing is initiated.
The output of the thermocouple located on the sample indicates when freezing begins. At
Preceding Page Blank
A-3
this point, the liquid nitrogen can be turned on at full flow to provide maximum cooling.
However, the response of the cooling-gas temperature is not fast enough to maintain the
required cooling.
Attempts to program the freezer to provide more or less cooling at different phases of the
freezing process are unsuccessful because: (1) the time that the phase changes occur can vary
from sample to sample, and (2) the freezer cooling gas cannot change temperature quickly
enough.
In pursuing an improved design, initial efforts were directed to concepts that use liquid
cooling. The first concept considered was that which was proposed by Dr. Ronald Yankee*
(figure A-l).
BAG SENSOR
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LN., CHANNELS
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Figure A-1. Concept I: Freezing system using LN2 for cooling.
White blood cells in a solution are contained in a bag, and cooling is supplied by the liquid
nitrogen flowing through the system. A heater located between the liquid-nitrogen tubes
and the bag controls the cooling rate during the cooling of the liquid and solid phases.
When the freezing point is reached, heating is discontinued so that a sharp increase in cooling
occurs to remove the latent heat of fusion from the liquid. A modified Wheatstone Bridge
circuit was proposed for regulating the temperature of the solution being frozen.
*"Method of Controlling Rate of Cooling in Liquids," Dr. Ronald Yankee, Report No. NTI/NCI-4, National Cancer
Institute, July 1971.
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After some preliminary analysis, it was concluded that the concept shown in figure A-l
is impractical for a number of reasons. First, a prohibitive amount of power would be required
to control the cooling rate if the liquid nitrogen flowed continuously. For example, with
a 28- by 28-cm single bag, if liquid nitrogen flowed in the channels on only one side of the
bag, about 1.5 kilowatts would be required to control the cooling rate. Moreover, a considerable
amount of liquid nitrogen would be required.
Freezing from one side of the bag only is undesirable because temperature gradients exist
across the thickness of the liquid to be frozen. The liquid is a comparatively poor thermal
conductor and, consequently, should be in a thin layer with maximum surface available to
the cooling media. It is therefore preferable to clamp the bag between two channels that
contain liquid nitrogen. This system would be impractical to fabricate and use conveniently.
Moreover, the system would not be easily adaptable to freezing multiple bags of blood, and
the heater power would become even more prohibitive.
Another problem with this concept is that some of the design requirements conflict with
each other. To control cooling rates with a reasonable heater power, a large thermal impe-
dance and a low thermal capacity is desirable between the liquid nitrogen and the heater.
On the other hand, the requirement for "instantaneous" removal of the heat of fusion dic-
tates a minimal thermal impedance between the liquid nitrogen and the blood bag.
The removal of the latent heat of fusion requires some finite time no matter which type of
freezing system is used. The various components of the system possess a wide range of
thermal properties. During the actual freezing, these components will cool at different rates.
It would be very difficult to regain control of the system after the liquid has completely
frozen.
Finally, because of the severe temperature differentials and transient variations in the system,
it would be difficult to keep the joints leak-free during expansion and contraction.
Figure A-2 depicts a concept that attempts to eliminate some of the shortcomings of the
first concept. In this concept, a controlled temperature surface is maintained to act as the
heat sink for the cooling of the blood. This surface is separated from the surface on which
the heater is mounted by either an insulating material or fins of the same materials as the
two surfaces.
The quick-freezing capability would be accomplished by flooding the area in which the fins
are located to cool the surface on which the heater is located down to liquid-nitrogen tem-
perature.
Values were estimated for all parameters except for the A2, the area of the fins, as follows:
Tt 173K
A, 280cm2 (14 by 20)
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T7T6T5T4T3 T2T1
Figure A-2. Concept II: White blood-cell freezing system.
A2 To be determined
Lt 0.1 cm
L2 1.3 cm
L3 0.025 cm
L4 0.025 cm'
L5 0.09 cm
L, 0.038cm
o
Assuming that the heater would be at 293 K with the system on when the bag was inserted,
and assuming that the heat transfer is the same throughout all parts of the system (i.e.,
a hold mode), A2 = 2.4 cm2 when the fins are brass, and a maximum of 200 watts is allowed
for heater power. This area is too small for practical fabrication.
One method of solving this problem is to use a thermal insulator for the fin material.
For example, if a material with a thermal conductivity of 0.01 that of brass were used for the
fins, A2 could be made nearly equal to Aj. The practicality of fabrication with dissimilar
materials is difficult, and high thermal stresses would exist.
A calculation to determine the approximate freezing time possible with the Concept II
system (figure A-2) was done by assuming the temperature of the brass nearest the bag to
be 77 K while the blood was at 253 K. The fluid was assumed to have the same latent
heat of fusion as water. The time was calculated to be 65.8 seconds. With a thinner heater, the
freezing time could be reduced by approximately a factor of 3.
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A breadboard model of Concept II, in slightly modified form, was fabricated and tested
(figure A-3). The temperature-controlled surface was maintained by controlling the flow
of nitrogen gas through a cooling coil attached to the surface. The purpose of these tests
was to evaluate the proposed design.
Initial tests were conducted by blowing liquid nitrogen through the system while thermo-
couples monitored the outside temperature. The system held up well mechanically, but
the tremendous pressure from the nitrogen gas caused the upper section to "oil-can"
considerably.
HEATER
INSULATION
BAG \ LN2 OUTLET
Figure A-3. Breadboard test model of Concept II freezing system.
After the first series of tests, two 80-watt 1-mm thick heaters were epoxyed to the front
brass plate. Thermocouples were placed on the heater surfaces and on the back of the brass
plate. Attempts were made to maintain a constant temperature of 200 K on the back plate
by blowing liquid nitrogen through the coils while keeping the heaters at 296 K. At a given
time, the heater was turned off and liquid nitrogen was flooded through the system. Tem-
peratures were again monitored during this test.
Finally, a test was conducted with 100 milliliters of tap water placed in a 10-by 10-cm plastic
bag secured to the heaters. With the 100 milliliters of liquid, the bag was about 0.65 cm
wide. Thermocouples were placed in the water, on the heater, and on the back of the sys-
tem. Again, attempts were made to initially maintain constant temperatures of 200 K and
296 K on the back of the plate and in the water, respectively. At a given time, both the
cooling of the back plate and the power to the heater were halted, and liquid nitrogen was
flooded through the coils. The data and observations from these tests indicated three
weaknesses in the proposed design:
1. The cooling ability was below expectations, with a minimum average temperature
on the outer plate leveling off at 145 K.
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2. The pressure from the nitrogen gas was so great that, by the end of the series
of tests, there was evidence of broken connections between the front plate
and the upper fins.
3. Adequate temperature control was found to be impossible; during the final
test, all attempts to hold the water at 296 K and the back plate at 200 K
x - failed.
At this point, it was concluded that a gaseous cooling system offered the best solution. The
plan pursued was to use the basic type of cooling system then in use at NCI. Efforts were
then directed at improving the general system by:
• Using improved control techniques
• Obtaining a bag (used to hold the blood) with better thermal properties
• Designing a better bag holder
• Optimizing the cooling rates
• Placing the control thermocouple in a more optimum location
These efforts resulted in the system described in the main text of this document. The new sys-
tem is better than the system previously used by NCI because:
• The temperature at the surface of the container that holds the sample to be
frozen is precisely controlled.
• The cooling gas is lowered to a level below that required at any time other than
when latent heat is to be removed. When the high cooling rate is not needed, a
heater on the container provides heat to compensate for the excessive cooling
capacity. When the latent heat is being removed, the high cooling rate is immed-
iately available by turning off the heater.
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APPENDIX B
COMPUTER PROGRAM LISTING
-.JOB
-.FORTRAN LS,HO
c
C * DIMENSION. STATEMENTS *
r sj; sjs 'ff. -'f. ?£. ^ : y,: ;^  X: ^ 5j- v # # X" •£ # •'£ ^  ;I* # ^  -r J
D I HENS ION RHO( 20) ,C.P(?0) .CONDI ?0) , X ( 20)
0 1 HENS ION R(?0) , C (20), CM I 20 )
01 MEMS ION Al (20) , A2 (20) , A3( 20)
DIMENSION T( 20) ,TF (?()),(.!( 20 ) , K( 20)
* READ PROGRAM CHNSTAK'TS *
c
C T A t l = INITIAL TIME, TAIJM = F INAL T IME, D T A U = T IME I MCK EMIrWT , T A O P K =
C INCREMENT, TAUPU = PUNCH INCREMENT
C TSS = STEADY STATE TEMPERATURE ( I N I T I A L ) , FT = FREEZING TEMPERATURE
C AA, BB, AND CC ARE INPUT TEMPERATURE CONTROL PARAMETERS '
C M = NUMBER OF NODES, NL = NUMBER OF M A T E R I A L LAYERS, MOHTC INDICATES IF HTC
C VALUE IS TO BE USED, ( 0 IF YES , 1 IF HTC EOUALS I N F I N I T Y )
C HTC = HEAT TRANSFER COEFFICIENT, HF = HEAT OF FUSION, AR = CROSS SECTIONAL
C A'R F A
C
C
READ 1. ' TAU, TAUM, DTAU, TAUPR
PRINT 1, TAU, TAUM, DTAU, TAUPR
READ 2, TSS, FT, AA, BB
PRINT 2, TSS, FT, AA, BB
READ 3, M, NL
PRINT 3, M, NL
READ 4,HF,AR
PRINT 4,HF,AR
MM=1+M
NL1 = NL + 1
NL2 = NL + 2
NL3 = NL + 3
C
C * READ MATERIAL PROPERTIES *
c
C DENSITY, SPECIFIC HEAT, THERMAL CONDUCTIVITY, LENGTH, HEAT GENERATED
C
Preceding Page ««""*
DO 70 1=1, ML2
READ 5, RHO(I), CPU), COMD(I), X(I)
PRIMT 5, RHO(I), CPU), CONDI I), X I I )
70 CONTINUE
C
C * SET I N I T I A L CONDITIONS *
C ***«**^.>te*****«*********«*«
C
TAUA = TAU
Ml = M + 1
MB = M-NL2
X(NL1 ) = X I N L 1 I/MB
DO 80 N = 2, MM
SO T(N)=TSS
DO 90 N=NL3,M1
0(N ) = 0.0
KIN) = 0
R I N ) = RHOINL1 ),
CIN) = CPINL1 )
90 CNIN) = CONDINL1)
CN(Ml) = 0.0
R(4)=R(4>*1 .5
C
Q % # # $ # £ & & # & * * * # ~'f * # * * # # # -I' * * * # * * & * * # ^  ^ * V ^  -r * & X -f * *
C * COMPUTE M A T E R I A L TEMPERATURE COEFFICIENTS *
A 1 I M L 2 ) = CONDIMI. )/( RHOINL )*CP(NL )*(X(NL )/2. )*X(NL ) )
F = HF*RHO(NL1 )*X(NL 1 )*AR
C
110 A2INL2) = CNINL3)/ I RHO I NL ) *CP ( NL ) *( X ( NL ) /2 . 0 ) *X ( ML 1 ) )
C
£ £ * # # ^ * * * * * * * # # * # * * * * * * * * * # * * £ * * * * >? * # $ # V ^ * * # 'r * * £ -.- * * *
C * COMPUTE INPUT TEMPERATURE AS A FUNCTION OF TI'ME *
C
119 T i l ) = A-A + BB*TAU
T(2)=T( 1 )
C
C * COMPUTE TEMPERATURES IN THE M A T E R I A L S *
Q $$$****>!:*****#******«**«*««:):#**«<:*#«*****
C
N=3
TF(N) = DTAU*A1(N)*T(N-1) + ( 1 . -DTAU* ( A 1 1 N ) +A2 I N ) ) ) *T( N ) + DTAU*
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1A2(N)*T('N + 1 )
130 N = N + l
IF<K(N)-rl) 500,700,900
C
C *******************
C * NODE NOT FROZEN *
C *******************
C
500 Bl =CN(N)/(C(N)*R<N)*X<Nll) **2 I
B2 = CN<N+1)/(C(N)*R(N)*X(NL1)**2)
TF(N) = DTAU*Bl*T(N-l ) + ( 1.-DTAll*(B1+B2 ) ) *T(N ) + DTAU*B2*T(N+l )
IF(TFIN)-FT) 550,550,1000
550 K I N ) = 1
PRINT 88
TF(N) = FT
GO TO 1000
C
Q ************************
C * NODE IS NOW FREEZING *
C ************************
C
700 TF(N) = FT
OA = DTAU*AR/X(Nll)* (CN(N)'* (T(N ) -T(N- 1 ) ) -CN(M + l ) * (T(N+1)-T(M)
1) )
0(N) = OIN1+OA
R(N) = RHOINL1 )*( 1.0-0(N)/F)+(,MN) /F*RHO(NL2)
R(4) = (RHO(NLl)*tl.0-0(4)/F)+0(4 I/F*RHQ(ML2 ) )*1.5
C(N) = CP(NLl)* (l.O-O(N)XF) +• 0<N)/F*CP(NL2)
CN(N) = CONDINL 1 )*( 1.0-OIN )/F ) + 0 ( N ) /F*Cf)ND ( ML2 )
IF-I 0(M)/F-1 . ) 1000,750,750
750 KIN) = 2
GO TO 1000
C
C ****************************
C * NODE HAS NOW BEEN FROZEN *
C ****************************
C
900 Bl = CN<N)/<C(N)*R(N)*X(NL1)**2)
B2 = CNIN+1)/(C(N)*R(N)*X(NL1)**2)
TF(N) = DTAU*B1*T(N-1) + ( 1.-DTAU*(B1 + B2) ) *T(N ) + DTAU*B2*T(N+ 1 )
C
LOOO IF(N-M) 130,1010,1010
C
C ***********************************
C * 'STEP UP1 TEMPERATURES AND TIME *
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•1010
1.020
DO 1020 N = 3,M
T I N ) = T F ( N )
T ( M M ) = T ( M - 1 )
TAU = TA-U + D T A U
c
c
c
c
* OUTPUT S T A T E M E N T S
IF!TAU-TAUA) 1060,1030,1030
1030 CONTINUE
PRINT 7, (TIN), N=1,M)
PRINT 7, TAU
TAUA = TAUA + TAUPR
C
c
c
c
c
c
c
1.060
1200
IFI TAU-TAUM) 1 10,1200, 1200
CONTINUE
*********************
* FORMAT .STATEMENTS *
******* **************
1
2
3
4
FORMAT!
FORMAT!
FORMAT!
FORMAT (
4! F15.
2 ( F 1 0 .
21 10)
2IF15.
5 FORMATI4! F15.
6
7
88
-.LOA,D
FORMAT (
FORMAT(
FORMAT I
END
X
/ , F 1 0 .
101F.10
/ , 1 H * )
7) )
3,-5X),5X,2(F15.71)
7,5X) )
7) )
3 ,/ )
.3,3X1 )
-.DATA
0.0
6.0
6
79.71
.925
1.0
1.0
3000.
0.0
1
1.0
.55
1.0
.44
.01 60.
6.00
.000785
.0014
.004
-.016667
.0254
.1255
.1255
-.•FIN
0177 CARD;,
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APPENDIX C
CONTAINER DRAWINGS
2 I
(a) FRAME
(b) PLATE
Figure C-1. Bio-pack (5 by 15 cm).
^receding Page Blank C-3
RIB.
\
SIDE FRAME
(SK740211-1)
PACK PLATE
(SK740212-2I
SIDE FRAME
(SK740211-2)
' STRINGER
(SK740212-1)
Figure C-2. Bio-pack structure (30 by 30 cm).
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Figure C-3. Bio-pack plate.
Figure C-4. Bio-pack stringer.
U
o o
~M If IT
Figure C-5. Bio-pack main rib.
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(a) SK740211-2
.Q.QQ.QQ.QQQQ.QQ.Q
(b) SK740211-1
Figure C-6. Bio-pack side frames.
(a) UPPER
o oo
(b) LOWER
Figure C-7. Bio-pack end frames.
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